Drug combination composition for type 2 diabetes and liver injury and application of drug combination composition
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU DAYSEBIOTECH LTD
- Publication Date
- 2021-05-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biomedicine, in particular to a combination medicine composition for type 2 diabetes and liver injury and application thereof. Background technique
[0002] Diabetes is a metabolic disease characterized by hyperglycemia. Long-term hyperglycemia can lead to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. Diabetes is one of the most important chronic non-communicable diseases in the world, and is an important global health problem. The global diabetes map released by the International Diabetes Federation in 2017 shows that the number of people with diabetes has reached 425 million, of which type 2 diabetes is diabetes main types of . In recent years, with the development of socio-economic level, changes in population structure and changes in the lifestyle of the whole people, the incidence of diabetes has been increasing year by year. China has becom...